Anzeige
Mehr »
Samstag, 10.01.2026 - Börsentäglich über 12.000 News
Fundamental stark, Kurs zu niedrig - Chance beim Krebs-Impfstoff-Pionier!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU79 | ISIN: US71639T1060 | Ticker-Symbol: N/A
1-Jahres-Chart  (nicht börsennotiert)
PETIQ INC Chart 1 Jahr
GlobeNewswire (Europe)
257 Leser
Artikel bewerten:
(1)

PetIQ, Inc.: PetIQ Names Camillo Pane as Chief Executive Officer

Accomplished Consumer Goods and Health Care Leader
Would Bring Decades of Leadership Experience to Role

EAGLE, Idaho, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company"), a leading pet medication, health and wellness company and portfolio company of Bansk Group, is pleased to announce that Camillo Pane would join PetIQ as Chief Executive Officer, effective February 17, 2025. Mr. Pane would succeed Cord Christensen.

Mr. Pane's passion for making a difference in the lives of consumers has been a constant focus throughout his more than 30-year career. His drive and commitment in this area has led to strong share gains and profitable growth at a variety of iconic consumer and pet health and wellness brands and businesses. Most recently, he served as Group CEO of Health & Happiness Group, a global health and nutrition company. Previously, he served as CEO of Coty, one of the largest beauty companies in the world, where he led the company through a merger with the P&G Specialty Beauty business. Before that, he spent a highly successful career of nearly 20 years at Reckitt Benckiser in mostly consumer health-focused operational and strategic roles. He currently also serves as Chairman of Alliance Pharma plc, a global consumer health company.

"PetIQ is a unique force for innovation within the pet health and wellness space, and it would be a tremendous honor to lead this company into its next chapter," said Mr. Pane. "Throughout my career, I have been driven by an enduring commitment to accelerate growth, drive value creation and deliver the highest-quality products and experiences for the consumers I've served. I am excited for the opportunity to do that alongside the talented team at PetIQ as it expands access to convenient, affordable veterinary services and continues to grow its offering of health products that help pets live their best lives."

"We are thrilled with the opportunity to have a leader with Camillo's depth of knowledge and expertise to join the PetIQ family," said Bart Becht, Senior Partner at Bansk and PetIQ Board spokesperson. "Having known Camillo for over 25 years, I have witnessed firsthand his dedication to building iconic brands and executing meaningful, long-term growth strategies that have a distinct consumer impact and drive profitable growth, and I am confident he will be the right leader for PetIQ's next chapter. I look forward to supporting him when he starts his new role."

Mr. Becht continued, "On behalf of the Board, I would like to express our gratitude to Cord for his 15 years of leadership and for the strong foundation he helped establish as CEO. We wish him well in his future endeavors."

About PetIQ

PetIQ is a leading pet medication, health and wellness company delivering a smarter way for pet parents to help their pets live their best lives through convenient access to affordable products and veterinary services. The Company's product business engages with pet parents through retail and e-commerce sales channels with its branded and distributed pet medications as well as health and wellness items. PetIQ manufactures and distributes pet products from its world-class facilities in Omaha, Nebraska, Springville, Utah and Daytona Beach, Florida. The Company's veterinarian services offering operates in over 2,600 mobile community clinic locations and wellness centers hosted at retail partners in 39 states. PetIQ believes that pets are an important part of the family and deserve the best products and care we can provide them.

Contacts

Media:
Erik Carlson / Woomi Yun / Madeline Jones
Joele Frank, Wilkinson Brimmer Katcher
+1 (212) 355-4449


© 2025 GlobeNewswire (Europe)
Gold & Silber auf Rekordjagd
Kaum eine Entwicklung war 2025 so eindrucksvoll wie der Höhenflug der Edelmetalle. Allen voran Silber: Angetrieben von einem strukturellen Angebotsdefizit, explodierte der Preis und übertrumpfte dabei den „großen Bruder“ Gold. Die Nachfrage aus dem Investmentsektor zieht weiter an, und ein Preisziel von 100 US-Dollar rückt in greifbare Nähe.

Auch Gold markierte neue Meilensteine. Mit dem Durchbruch über 3.000 und 4.000 US-Dollar pro Unze hat sich der übergeordnete Aufwärtstrend eindrucksvoll bestätigt. Rücksetzer bleiben möglich, doch der nächste Zielbereich bei 5.000 US-Dollar ist charttechnisch fest im Blick. Die fundamentalen Treiber sind intakt, eine nachhaltige Trendwende aktuell nicht in Sicht.

Für Anlegerinnen und Anleger bedeutet das: Jetzt ist die Zeit, um gezielt auf starke Produzenten zu setzen. In unserem neuen Spezialreport stellen wir fünf Gold- und Silberaktien vor, die trotz Rallye weiter attraktives Potenzial bieten, mit robusten Fundamentaldaten und starken Projekten in aussichtsreichen Regionen.

Jetzt den kostenlosen Report sichern und von der nächsten Welle im Edelmetall-Boom profitieren!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.